Audemars Piguet Pricing Trends Heading Into 2026

After years of huge demand and big secondary premiums, Audemars Piguet prices are entering a more selective phase. Buyers heading into 2026 are noticeably more careful.

From peak hype to a reset

Between 2020 and 2022, Audemars Piguet saw one of the sharpest demand surges in modern watchmaking. Royal Oak models that used to come through relationships and patience became speculative assets almost overnight.

Heading into 2026, prices reflect a return to normal rather than a decline. Buyers are slowing down, asking better questions and thinking about owning for the long term instead of a quick gain.

Royal Oak fatigue

The Royal Oak is still the heart of the brand, but years of attention on that one line have saturated the market. Even strong references take longer to sell on the secondary market.

Buyers who once chased any available piece at any price now wait for the right example. That doesn’t weaken the Royal Oak. It just takes the urgency out of buying one.

Allocation vs secondary prices

AP sells new pieces only through its own boutiques, which still limits access. But scarcity alone no longer justifies a big secondary premium. Collectors have learned that a watch being hard to buy doesn’t mean it will rise in value. Many now choose patience over overpaying, even when a piece is technically available.

How fast AP sells on the secondary market

How easily a piece sells has become the measure that matters most for AP. Some references still trade smoothly. Others sit, despite the brand’s appeal. Dealer spreads have widened, negotiation is back and stock moves more slowly.

For buyers, that means leverage. For sellers, it means realistic prices and patience.

What AP buyers can expect in 2026

AP prices in 2026 are likely to reward discipline, not speed. The days when prices only went up are largely over. Well-chosen references should hold their value, but buying to flip without a plan to sell carries more risk than before.

A Royal Oak still makes sense when you buy it to own and wear. For patient buyers, this market offers more room to negotiate than recent years did.